Related Experiment Videos
Slowly developing perigraft seroma after a modified Blalock-Taussig shunt
K Matsuyama1, M Matsumoto, T Sugita
1Department of Cardiovascular Surgery, Tenri Hospital, 200 Mishima, Tenri, Nara 632-8552, Japan.
Pediatric Cardiology
|January 11, 2003
Summary
A rare perigraft seroma developed 15 years after a modified Blalock-Taussig shunt. Histology confirmed seroma, with no recurrence after 1 year.
Area of Science:
- Cardiovascular Surgery
- Medical Imaging
- Pathology
Background:
- Modified Blalock-Taussig shunts using expanded polytetrafluoroethylene (ePTFE) grafts are used to treat congenital heart disease.
- Long-term complications of these grafts, such as seroma formation, are infrequently reported.
Observation:
- A 26-year-old patient presented with a mediastinal mass 8 years after a modified Blalock-Taussig shunt.
- The mass, adjacent to a calcified but functioning ePTFE graft, contained gelatinous tissue with a calcified pseudocapsule.
- No fluid collections were initially detected on imaging.
Findings:
- Histopathological examination confirmed the mediastinal mass to be a perigraft seroma.
- The seroma developed slowly, 15 years after the initial shunt procedure.
- The patient showed no signs of recurrence 1 year after surgical intervention.
Implications:
- This case highlights a rare, late-onset complication of ePTFE grafts used in cardiovascular surgery.
- It underscores the importance of long-term surveillance for patients with modified Blalock-Taussig shunts.
- Understanding the pathogenesis of perigraft seromas can inform future surgical techniques and patient management.